Skip to content

Dossier · PLTK · Dormant

PLTK · Playtika Holding Corp. · Stock research

Last analysed ·

Current thesis

PLTK — research research dossier: thesis, invalidation trigger, archetype.

Current Thesis

_(no analysis yet — pending first synthesis or watchlist research)_

Bullish and bearish views on Playtika Holding Corp.

Bull Case

_(pending)_

Bear Case

_(pending)_

Setup & Price Structure

_(pending)_

Catalyst Calendar (next 30 days)

_(pending)_

What Would Change Our Mind

_(pending)_

Correlation Notes

_(pending)_

Related · shared themes

MTUM

May 2026 reconstitution rotated MTUM hard into the AI-memory/semiconductor complex (MU 7.2%, INTC, AMD, AVGO, LRCX, AMAT ~30%+ combined); the factor now trades as a leveraged AI-hardware proxy, +30% YTD and pressed against its $345.59 52-week high. Underlying accelerating, but crowded and late in the reconstitution cycle.

LOW

WEST

Westrock Coffee Company

Conway extract/RTD platform inflecting capex to cash: Q1 (5/07) beat revenue with record adjusted EBITDA, FCF-positive-H2 guide reaffirmed, and a 6/30 debt-maturity extension cleared the near-term refi wall. Stock re-rated ~the published invalidation level→$9.50 near the $9.81 high on PT hikes real and accelerating, but a fresh entry above the ~$8.88 average PT into an ~8-week gap to Q2 (~8/6) is extended.

LOW

ALGT

Allegiant Travel Company

A three-week sell-side upgrade cascade (Goldman $125→$142, JPM initiates OW $156, Citi/Melius Buy $156–$160, Barclays OW $145) plus a fuel-cost tailwind as the Hormuz crude spike unwinds has re-rated Allegiant's post-Sunseeker ULCC turnaround. Theme is accelerating with the whole airline complex (JETS at pre-Covid highs), but the move has more than doubled off the low into a seasonally soft Q2 print on ~2026-08-03.

HIGH

AFRM

Affirm Holdings, Inc.

Q3 FY26 killed the credit-stress bear case (GMV +35%, first GAAP operating profit, clean delinquency), and a July sell-side cluster six PT raises/initiations to $96–$117 in ten days is accelerating the re-rate off the mid-June 200-day reclaim (~$74). Momentum confirms, but the move is stretched into a maturing analyst pile-in near the prior $100 high, with no company catalyst until the ~mid-August print.

MEDIUM

See also · stocks to watch